Difference between revisions of "Part:BBa K2278021:Design"
(→Source) |
|||
| Line 17: | Line 17: | ||
The peptides DNA sequence has been obtained by reverse translate the amino acid sequence of the NY15 proposed by Yaraksa et al., 2013 which was determined by mass spectrometry analysis. | The peptides DNA sequence has been obtained by reverse translate the amino acid sequence of the NY15 proposed by Yaraksa et al., 2013 which was determined by mass spectrometry analysis. | ||
| − | + | ||
===References=== | ===References=== | ||
| + | Yaraksa, N., Anunthawan, T., Theansungnoen, T., Daduang, S., Araki, T., Dhiravisit, A. and Thammasirirak, S. (2013). Design and synthesis of cationic antibacterial peptide based on Leucrocin I sequence, antibacterial peptide from crocodile (Crocodylus siamensis) white blood cell extracts. The Journal of Antibiotics, 67(3), pp.205-212. | ||
Revision as of 23:04, 17 October 2017
D-NY15 Antimicrobial peptide with Alpha-Factor Secretion Signal
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 244
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Part:BBa_K431009 : glyceraldehyde 3-phosphate dehydrogenase promoter (pGAP)
Part:BBa_K1800001:Design Alpha-Factor Secretion Signal
Source
The peptides DNA sequence has been obtained by reverse translate the amino acid sequence of the NY15 proposed by Yaraksa et al., 2013 which was determined by mass spectrometry analysis.
References
Yaraksa, N., Anunthawan, T., Theansungnoen, T., Daduang, S., Araki, T., Dhiravisit, A. and Thammasirirak, S. (2013). Design and synthesis of cationic antibacterial peptide based on Leucrocin I sequence, antibacterial peptide from crocodile (Crocodylus siamensis) white blood cell extracts. The Journal of Antibiotics, 67(3), pp.205-212.